Zachary Klaassen1, Lauren Howard2, Martha K Terris3, William J Aronson4, Matthew R Cooperberg5, Christopher L Amling6, Christopher J Kane7, Stephen J Freedland8. 1. Medical College of Georgia-Georgia Regents University, Augusta, GA, United States. 2. Duke University Medical Center, Durham, NC, United States. 3. Medical College of Georgia-Georgia Regents University, Augusta, GA, United States; Augusta Veterans Affairs Medical Center, Augusta, GA, United States. 4. West Los Angeles Veterans Affairs Medical Center, West Los Angeles, CA, United States; University of California, Los Angeles School of Medicine, Los Angeles, CA, United States. 5. San Francisco Veterans Affairs Medical Center, San Francisco, CA, United States; University of California, San Francisco, CA, United States. 6. Oregon Health & Sciences University, Portland, OR, United States. 7. San Diego Veterans Affairs Medical Center, San Diego, CA, United States; University of California, San Diego, CA, United States. 8. Durham Veterans Affairs Medical Center, Durham, NC, United States; Cedars Sinai Medical Center, Los Angeles, CA, United States. Electronic address: stephen.freedland@cshs.org.
Abstract
OBJECTIVES: To assess whether larger tumor volume in black men explains higher presurgical PSA levels versus white men with prostate cancer. METHODS: We retrospectively analyzed 1904 men from the Shared Equal Access Regional Cancer Hospital database who underwent radical prostatectomy from 1990 to 2013. Geometric mean of tumor volume and preoperative PSA for each race were estimated from multivariable linear regression models. RESULTS: There were 1104 (58%) white men and 800 (42%) black men. Black men were younger (60.2 vs. 62.9 years, p<0.001) had a higher PSA (6.7 vs. 6.0 ng/mL, p<0.001), more positive margins (47 vs. 38%, p<0.001), and seminal vesicle invasion (13 vs. 9%, p=0.007). White patients had higher clinical stage (p<0.001) and greater median tumor volume (6.0 vs. 5.3 gm, p=0.011). After multivariable adjustment (except for PSA), white men had smaller mean tumor volumes (5.2 vs. 5.8 gm, p=0.011). When further adjusted for PSA, there was no racial difference in mean tumor volume (p=0.34). After multivariable adjustment, black men had higher mean PSAs vs. white men (7.5 vs. 6.1 ng/mL, p<0.001). Results were similar after further adjusting for tumor volume: black men had 16% higher mean PSAs versus white men (7.4 vs. 6.2 ng/mL, p<0.001). CONCLUSIONS: In this study of men undergoing radical prostatectomy at multiple equal access medical centers, racial differences in tumor volume did not explain higher presurgical PSA levels in black versus white men. The exact reason for higher PSA values in black men remains unclear.
OBJECTIVES: To assess whether larger tumor volume in black men explains higher presurgical PSA levels versus white men with prostate cancer. METHODS: We retrospectively analyzed 1904 men from the Shared Equal Access Regional Cancer Hospital database who underwent radical prostatectomy from 1990 to 2013. Geometric mean of tumor volume and preoperative PSA for each race were estimated from multivariable linear regression models. RESULTS: There were 1104 (58%) white men and 800 (42%) black men. Black men were younger (60.2 vs. 62.9 years, p<0.001) had a higher PSA (6.7 vs. 6.0 ng/mL, p<0.001), more positive margins (47 vs. 38%, p<0.001), and seminal vesicle invasion (13 vs. 9%, p=0.007). White patients had higher clinical stage (p<0.001) and greater median tumor volume (6.0 vs. 5.3 gm, p=0.011). After multivariable adjustment (except for PSA), white men had smaller mean tumor volumes (5.2 vs. 5.8 gm, p=0.011). When further adjusted for PSA, there was no racial difference in mean tumor volume (p=0.34). After multivariable adjustment, black men had higher mean PSAs vs. white men (7.5 vs. 6.1 ng/mL, p<0.001). Results were similar after further adjusting for tumor volume: black men had 16% higher mean PSAs versus white men (7.4 vs. 6.2 ng/mL, p<0.001). CONCLUSIONS: In this study of men undergoing radical prostatectomy at multiple equal access medical centers, racial differences in tumor volume did not explain higher presurgical PSA levels in black versus white men. The exact reason for higher PSA values in black men remains unclear.
Authors: H S Kim; D M Moreira; J Jayachandran; L Gerber; L L Bañez; R T Vollmer; A L Lark; M J Donovan; D Powell; F M Khan; S J Freedland Journal: Prostate Cancer Prostatic Dis Date: 2011-04-26 Impact factor: 5.554
Authors: Ricardo F Sanchez-Ortiz; Patricia Troncoso; Richard J Babaian; Josep Lloreta; Dennis A Johnston; Curtis A Pettaway Journal: Cancer Date: 2006-07-01 Impact factor: 6.860
Authors: Christopher R Mitchell; Eric C Umbreit; Laureano J Rangel; Eric J Bergstralh; R Jeffrey Karnes Journal: Urology Date: 2011-08-16 Impact factor: 2.649
Authors: Jeannette T Bensen; Zongli Xu; Gary J Smith; James L Mohler; Elizabeth T H Fontham; Jack A Taylor Journal: Prostate Date: 2012-05-01 Impact factor: 4.104
Authors: Douglas K Price; Cindy H Chau; Cathee Till; Phyllis J Goodman; Caitlin E Baum; Sandy B Ockers; Bevin C English; Lori Minasian; Howard L Parnes; Ann W Hsing; Juergen K V Reichardt; Ashraful Hoque; Catherine M Tangen; Alan R Kristal; Ian M Thompson; William D Figg Journal: J Urol Date: 2010-10-16 Impact factor: 7.450
Authors: John C Mavropoulos; Alan W Partin; Christopher L Amling; Martha K Terris; Christopher J Kane; William J Aronson; Joseph C Presti; Leslie A Mangold; Stephen J Freedland Journal: Urology Date: 2007-06 Impact factor: 2.649
Authors: Bradley D Figler; Alwyn M Reuther; Nivedita Dhar; Howard Levin; Cristina Magi-Galluzzi; Ming Zhou; Eric A Klein Journal: Urology Date: 2007-10 Impact factor: 2.649
Authors: Leon Sun; Arthur A Caire; Cary N Robertson; Daniel J George; Thomas J Polascik; Kelly E Maloney; Philip J Walther; Danielle A Stackhouse; Benjamin D Lack; David M Albala; Judd W Moul Journal: J Urol Date: 2009-09-16 Impact factor: 7.450